Matinas exits biopharma, merges with GH Power to form NYSE-listed clean energy firm
What's the deal? Matinas BioPharma is combining with Canada's GH PowerDealroom has a profile for this one. Try Dealroom → to create a NYSE-listed clean energy and critical minerals company, while selling its drug platform to Azurity PharmaceuticalsDealroom has a profile for this one. Try Dealroom → for $4 million upfront plus up to $17.5 million in milestones and future mid-single-digit royalties.
How is it structured? A newly formed Ontario corporation, expected to be named GH Power International, will become the public parent of both GH Power and Matinas. A GHP International subsidiary will amalgamate with GH Power, and a separate Delaware subsidiary will merge into Matinas, leaving Matinas as a wholly owned unit.
What do they do? GH Power has built modular reactor systems that convert scrap metals and water into high-purity alumina, clean hydrogen, and thermal energy. Matinas, meanwhile, is offloading its lipid nano-crystal technology platform and lead candidate MAT2203 to Azurity, exiting drug development entirely.
What's the endgame? The combined company plans to accelerate commercialisation of GH Power's technology and expand project development across North America and Europe. It aims to target demand for behind-the-meter power, the onshoring of critical mineral production, and industrial decarbonisation.
Why now? The deal hands GH Power a public listing and access to capital markets. "Becoming a publicly traded company is expected to strengthen our access to capital, enhance our strategic visibility, and accelerate the commercialization of our proprietary modular reactor technology," said David White, chief executive officer of GH Power.
The signal: The transaction is a reverse-merger route to public markets, letting a private clean energy developer inherit a listed shell rather than pursue a traditional IPO. It also reflects Matinas pivoting away from biopharma to reposition around clean energy, hydrogen, and critical materials.
Read more: Business Insider
Image credit: jurvetson
